W. O’Shea

He most recently served as vice chairman and previously as president and COO of Sepracor. He had been SVP of sales and marketing and medical affairs for Zeneca Pharmaceuticals, a unit of Zeneca Inc.

  • 2007 Second Quarter

Added to: MAP Pharmaceuticals Inc. - Mountain View, CA

MAP is a biopharmaceutical company focused on new therapies that address the needs of neurology patients. Revenues are $62 million.